Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Atopic Eczema”

454 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 454 results

Testing effectiveness (Phase 2)Study completedNCT04836858
What this trial is testing

Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis.

Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 71
Large-scale testing (Phase 3)Study completedNCT03661138
What this trial is testing

Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AbbVie 272
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07782333
What this trial is testing

A Study Evaluating TRIV-573 in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Triveni Bio 90
Post-approval studies (Phase 4)Study completedNCT00119158
What this trial is testing

Combination Therapy for Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Children's Hospital of Philadelphia 90
Not applicableEnded earlyNCT04462055
What this trial is testing

Effectiveness of Dupilumab in Food Allergic Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Food Allergy
UMC Utrecht 3
Testing effectiveness (Phase 2)Ended earlyNCT04990440
What this trial is testing

Bermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Janssen Research & Development, LLC 6
Post-approval studies (Phase 4)Active Not RecruitingNCT05983068
What this trial is testing

Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis

Who this might be right for
Dermatitis Atopic
Sanofi 48
Large-scale testing (Phase 3)Looking for participantsNCT06775860
What this trial is testing

ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Beijing InnoCare Pharma Tech Co., Ltd. 552
Testing effectiveness (Phase 2)Active Not RecruitingNCT05509023
What this trial is testing

Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)

Who this might be right for
Atopic Dermatitis
Q32 Bio Inc. 102
Testing effectiveness (Phase 2)Study completedNCT06085521
What this trial is testing

LNK01001 Capsule in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Lynk Pharmaceuticals Co., Ltd 150
Testing effectiveness (Phase 2)Study completedNCT04643457
What this trial is testing

Test the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants and in Study Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
UCB Biopharma SRL 107
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06487000
What this trial is testing

Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Enzychem Lifesciences Corporation 150
Large-scale testing (Phase 3)UnknownNCT06383468
What this trial is testing

A Phase III Study to Evaluate the Efficacy and Safety of AK120 in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Akeso 420
Testing effectiveness (Phase 2)Study completedNCT05769946
What this trial is testing

Hemay005 in Adult With Atopic Dermatitis

Who this might be right for
Hemay005, Atopic Dermatitis
Ganzhou Hemay Pharmaceutical Co., Ltd 79
Testing effectiveness (Phase 2)UnknownNCT05905133
What this trial is testing

Evaluate the Safety and Efficacy of CBP-201 in Chinese Adult Subjects With Moderate to Severe AD

Who this might be right for
Atopic Dermatitis
Connect Biopharm LLC 360
Large-scale testing (Phase 3)Not Yet RecruitingNCT07767253
What this trial is testing

Evaluation of 611 in Chinese Children With Moderate to Severe Atopic Dermatitis(AD)

Who this might be right for
Dermatitis, Atopic
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 246
Not applicableLooking for participantsNCT07444801
What this trial is testing

Intervention With Tralokinumab in Patients With Moderate-to-severe Atopic Dermatitis With Genital Impact

Who this might be right for
Atopic Dermatitis (Moderate-to-severe) Involving the Genital Region
University Hospital Schleswig-Holstein 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07678645
What this trial is testing

The Safety and Efficacy of Upadacitinib in Refractory Autoimmune Related Cholangitis and Atopic Dermatitis With Moderate to Severe Itching

Who this might be right for
Primary Biliary Cholangitis (PBC)Primary Sclerosing Cholangitis (PSC)Atopic Dermatitis (AD)
RenJi Hospital 44
Testing effectiveness (Phase 2)Active Not RecruitingNCT07217015
What this trial is testing

KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Kymera Therapeutics, Inc. 200
Large-scale testing (Phase 3)Study completedNCT06224348
What this trial is testing

Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids

Who this might be right for
Dermatitis Atopic
Sanofi 643
Next Page